BAC vs SRPT · P/E 13, rev $113.10B vs rev $1.90B
Bank of America Corp (BAC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BAC and SRPT stock pages for the full models.
Not investment advice.